1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Biopharmaceutical Contract Manufacturing Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Biopharmaceutical Contract Manufacturing Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing demand for biologics and biosimilars production
- 5.1.2 Rising outsourcing trends in pharmaceutical manufacturing
5.2 Market Opportunities
- 5.2.1 Growth in demand for contract services in vaccine production
- 5.2.2 Expansion in emerging markets for contract manufacturing services
5.3 Future Trends
- 5.3.1 Shift towards more flexible and scalable manufacturing facilities
- 5.3.2 Rise of biopharmaceutical collaborations and partnerships
5.4 Impact of Drivers and Restraints
6. Europe Biopharmaceutical Contract Manufacturing Market Regional Analysis
6.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
6.2 Europe Biopharmaceutical Contract Manufacturing Market Revenue 2019-2028 (US$ Million)
6.3 Europe Biopharmaceutical Contract Manufacturing Market Forecast Analysis
7. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Product
7.1 Biologics
- 7.1.1 Overview
- 7.1.2 Biologics: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Biosimilar
- 7.2.1 Overview
- 7.2.2 Biosimilar: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Service
8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Fill and Finish Operation
- 8.2.1 Overview
- 8.2.2 Fill and Finish Operation: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Analytical and QC Studies
- 8.3.1 Overview
- 8.3.2 Analytical and QC Studies: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Packaging
- 8.4.1 Overview
- 8.4.2 Packaging: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Biopharmaceutical Contract Manufacturing Market Analysis – by Source
9.1 Mammalian
- 9.1.1 Overview
- 9.1.2 Packaging: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Microbial-Based Biologics/Non-Mammalian
- 9.2.1 Overview
- 9.2.2 Packaging: Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Biopharmaceutical Contract Manufacturing Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Biopharmaceutical Contract Manufacturing Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.1.3 UK: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
- 10.1.1.2 Germany:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.2.3 Germany: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
- 10.1.1.3 France:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.3.3 France: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
- 10.1.1.4 Russia:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.4.3 Russia: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
- 10.1.1.5 Italy:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.5.3 Italy: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
- 10.1.1.6 Rest of Europe:
Europe Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
- 10.1.1.6.3 Rest of Europe: Europe Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Biopharmaceutical Contract Manufacturing Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 AbbVie Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Ajinomoto Co. Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 General Electric Company
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lonza
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MERCK KGAA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Samsung Biologics
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 THERMO FISHER SCIENTIFIC INC
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 WUXI BIOLOGICS
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Biopharmaceutical Contract Manufacturing Market
